Nutritional implications of glucagon-like peptide receptor agonists
Anti-obesity treatment using incretin-based pharmacotherapy such as glucagon-like peptide receptor agonists (GLP-1 RAs),...
Read More
Diabetes Specific Nutritional Formulas in Type 2 Diabetes Management Consensus Statement: a tool for diabetes management
Abstract
Short sleep duration contributes to increased risk of developing type 2 diabetes and glucose dysregulation
BY Dr Giuliana Murfet | Dr. Shanshan Lin |
What is time-restricted eating and how could it be used to manage hyperglycaemia?
Our ability to obtain and consume food at all hours of the day is a common facet of modern-day society which has contributed...
Red Meat and Type 2 Diabetes
There is a growing body of evidence to suggest that plant-based eating patterns (particularly vegetarian and vegan diets) have benefits for both the...
Remission of type 2 diabetes
The prevalence of overweight and obesity continues to rise in Australia and is an underlying cause of impaired fasting glucose (IFG), impaired glucose...
Type 2 Diabetes Remission Position Statement
A joint position statement has been published from a collaboration of ADEA, ADS and Diabetes Australia.
...Bariatric Surgery for the Management of Type 2 Diabetes: A Review
Obesity is a major risk factor for the development of T2 Diabetes (T2D) with a 3-fold increased prevalence of diabetes...